[Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
D000328:Adult; D000368:Aged; D001201:Ascites / Q000188:drug therapy*; D002191:Canrenoic Acid / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000378:metabolism; D011245:Pregnadienes / Q000627:therapeutic use*; D013148:Spironolactone / Q000627:therapeutic use*
D011245:Pregnadienes; D013148:Spironolactone; D002191:Canrenoic Acid; D011188:Potassium
Effetto dello spironolattone e del K-canrenoato nella cirrosi ascitica. Studio in doppio-cieco.